Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-06-17
DOI
10.1038/s41467-021-24108-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glioma stem-like cells evade interferon suppression through MBD3/NuRD complex–mediated STAT1 downregulation
- (2020) Xiaoyan Zhan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Oxidative Stress in Cancer
- (2020) John D. Hayes et al. CANCER CELL
- Cancer Stem Cells: The Architects of the Tumor Ecosystem
- (2019) Briana C. Prager et al. Cell Stem Cell
- Challenges to curing primary brain tumours
- (2019) Kenneth Aldape et al. Nature Reviews Clinical Oncology
- Cancer Cells Co-opt the Neuronal Redox-Sensing Channel TRPA1 to Promote Oxidative-Stress Tolerance
- (2018) Nobuaki Takahashi et al. CANCER CELL
- Hypoxic Induction of Vasorin Regulates Notch1 Turnover to Maintain Glioma Stem-like Cells
- (2018) Jianghong Man et al. Cell Stem Cell
- Targeting Cancer Stemness in the Clinic: From Hype to Hope
- (2018) Caner Saygin et al. Cell Stem Cell
- Reactive oxygen species and cancer paradox: To promote or to suppress?
- (2017) Sehamuddin Galadari et al. FREE RADICAL BIOLOGY AND MEDICINE
- Cancer stem cells revisited
- (2017) Eduard Batlle et al. NATURE MEDICINE
- Targeting glioma stem cells through combined BMI1 and EZH2 inhibition
- (2017) Xun Jin et al. NATURE MEDICINE
- Purine synthesis promotes maintenance of brain tumor initiating cells in glioma
- (2017) Xiuxing Wang et al. NATURE NEUROSCIENCE
- Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor
- (2016) Shintaro Iwasaki et al. NATURE
- Mitochondrial ROS Signaling in Organismal Homeostasis
- (2015) Gerald S. Shadel et al. CELL
- Cancer stem cells in glioblastoma
- (2015) Justin D. Lathia et al. GENES & DEVELOPMENT
- Unravelling tumour heterogeneity—implications for therapy
- (2015) David A. Reardon et al. Nature Reviews Clinical Oncology
- A novel prohibitin-binding compound induces the mitochondrial apoptotic pathway through NOXA and BIM upregulation
- (2015) Cristina Moncunill-Massaguer et al. Oncotarget
- Emerging role of microRNA-27a in human malignant glioma cell survival via targeting of prohibitin
- (2015) WEI CHEN et al. Molecular Medicine Reports
- Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells
- (2014) Mario L. Suvà et al. CELL
- ROS Function in Redox Signaling and Oxidative Stress
- (2014) Michael Schieber et al. CURRENT BIOLOGY
- Stem cells and the impact of ROS signaling
- (2014) C. L. Bigarella et al. DEVELOPMENT
- Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species
- (2014) Li Pan et al. NATURAL PRODUCT REPORTS
- RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer
- (2014) Andrew L. Wolfe et al. NATURE
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
- (2014) Olivier L. Chinot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress
- (2013) H C Whitaker et al. BRITISH JOURNAL OF CANCER
- Prohibitin Ligands in Cell Death and Survival: Mode of Action and Therapeutic Potential
- (2013) Frédéric Thuaud et al. CHEMISTRY & BIOLOGY
- Expression of prohibitins on the surface of activated T cells
- (2012) Hajime Yurugi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Natural Anticancer Compounds Rocaglamides Inhibit the Raf-MEK-ERK Pathway by Targeting Prohibitin 1 and 2
- (2012) Gernot Polier et al. CHEMISTRY & BIOLOGY
- Raf activation by Ras and promotion of cellular metastasis require phosphorylation of prohibitin in the raft domain of the plasma membrane
- (2012) C-F Chiu et al. ONCOGENE
- The role and therapeutic potential of prohibitin in disease
- (2011) Arianne L. Theiss et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Signal transduction by reactive oxygen species
- (2011) Toren Finkel JOURNAL OF CELL BIOLOGY
- Regulation of reactive oxygen species in stem cells and cancer stem cells
- (2011) Chiharu I. Kobayashi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Reactive oxygen species, cellular redox systems, and apoptosis
- (2010) Magdalena L. Circu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling
- (2009) Andrew G. Cox et al. BIOCHEMICAL JOURNAL
- Prohibitins and the functional compartmentalization of mitochondrial membranes
- (2009) C. Osman et al. JOURNAL OF CELL SCIENCE
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Association of reactive oxygen species levels and radioresistance in cancer stem cells
- (2009) Maximilian Diehn et al. NATURE
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
- (2009) Dunyaporn Trachootham et al. NATURE REVIEWS DRUG DISCOVERY
- Prohibitin and mitochondrial biology
- (2009) Marta Artal-Sanz et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria
- (2008) C. Merkwirth et al. GENES & DEVELOPMENT
- Prohibitin-1 maintains the angiogenic capacity of endothelial cells by regulating mitochondrial function and senescence
- (2008) Michael Schleicher et al. JOURNAL OF CELL BIOLOGY
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now